Healthcare
LBO Italia sells Corvette to Recipharm
€100m equity consideration will be paid for 50:50 in cash and convertible bond
German healthcare deals on the decline
Healthcare deals in Germany have dipped, highlighting difficulties in the space
VC-backed ProQR files for $75m IPO
Sofinnova is company's largest shareholder
Patron divests Gracewell Healthcare
Exit comes in same week as Patron's acquisition of Murco Petroleoum's retail assets
NB Capital-backed Forward Pharma files for IPO
Danish biotech expected to raise up to $200m
Longwall invests £2.6m in CTC
Funds will be used to boost sales in the US
Auris' delayed IPO lists below initial price range
Number of shares on offer increased by more than 35% but price almost halved
Beringea et al. exit Altacor
NVM and Enterprise Ventures had also backed the business
HgCapital sells Voyage Care to investor consortium
Deal marks Duke Street's second ownership of the business
Forbion et al. sell Santaris Pharma to Roche for $450m
Deal includes $200m in performance-based payouts
Auris Medical 'delays' IPO
Listing could take place this week
Permira backs pan-European healthcare merger
Permira-backed newco will unite Mesa Group and Asteral
HTGF invests in Predemtec
HTGF has been active this month, completing its seventh investment
Bridges-backed Alina in second bolt-on
Alina has doubled in size with the addition of the new company
LDC makes 3x money on Penn sale
LDC bought the business from Gresham in 2007
PAI's DomusVi buyout financed with €355m in senior notes
Cash raised will be used to pay down DomusVi debt
New Japanese VC fund to invest in Europe
Former Mitsui Ventures CEO to lead new firm
Sofinnova-backed Auris announces price range
Float expected to be worth between £69-82m
Shares rise in VC-backed Abzena after £20m IPO
The offering gave Abzena a market cap of ТЃ77.9m
Summit picks up August's Independent Vetcare
Company attracted interest from trade and private equity
Eurazeo takes majority stake in Colisée
Deal values retirement home operator at around €175m
Specialisation sees healthcare investment return to Poland
Enterprise Investors' investment in oncology space reveals interesting development
bm-t invests in Inflarx series-B round
Second of two series-B tranches completed for Jena-based company
Deal in Focus: Doughty sells Quirón to CVC
Doughty reaped 2x money and 40% IRR on Quirón sale to CVC